In Brief | Published:

Fabry disease

Effects of agalsidase-β shortage in Fabry disease

Nature Reviews Nephrology volume 11, page 566 (2015) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Patients with Fabry disease after enzyme replacement therapy dose reduction and switch-2-year follow-up. J. Am. Soc. Nephrol. 10.1681/ASN.2015030337

Download references

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrneph.2015.139

Authors

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing